Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Pabinger

Showing results (151-160 of 367) with videos related to

Pageof 37
Sort By:
Oncology Research and Treatment|April 13, 2018
Immunthrombozytopenie - aktuelle Diagnostik und Therapie: Empfehlungen einer gemeinsamen Arbeitsgruppe der DGHO, ÖGHO, SGH, GPOH und DGTIAxel Matzdorff, Oliver Meyer, Helmut Ostermann, et al.
Annals of Hematology|February 3, 2011
Long-term survival of patients with a history of venous thromboembolismSylvia Elisabeth Reitter, Thomas Waldhoer, Michaela Mayerhofer, et al.
Thrombosis Research|August 19, 2007
Plasma levels of P-selectin are determined by platelet turn-over and the P-selectin Thr715Pro polymorphismSimon Panzer, Sergio Rosales, Heinz Gisslinger, et al.
Thrombosis and Haemostasis|August 12, 2008
Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patientsClaude Négrier, Amy Shapiro, Erik Berntorp, et al.
Thrombosis and Haemostasis|March 30, 2007
The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154Peter Bugert, Ingrid Pabinger, Kathrin Stamer, et al.
Wiener Klinische Wochenschrift|May 5, 2009
Austrian Hemophilia Registry: design, development and set of variablesSylvia Reitter, Werner Streif, Thomas Schabetsberger, et al.
Annals of Hematology|November 24, 2018
Low extracellular vesicle-associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosisLena Hell, Cihan Ay, Florian Posch, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 27, 2021
Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgeryIngrid Pabinger, Vasily Mamonov, Jerzy Windyga, et al.
Journal of Thrombosis and Haemostasis : JTH|May 16, 2025
Bleeding risk and performance of bleeding risk assessment models in patients with venous thromboembolism on anticoagulation: results from the prospective observational bleeding and assess long-term outcomes on health in patients with venous thromboembolism (BACH-VTE) studyTimothy Hoberstorfer, Stephan Nopp, Daniel Steiner, et al.
Thrombosis and Haemostasis|October 9, 2018
Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with CancerElla Grilz, Florian Posch, Oliver Königsbrügge, et al.
Pageof 37

Showing results (151-160 of 367) with videos related to

Sort By:
Pageof 37
Oncology Research and Treatment|April 13, 2018
Immunthrombozytopenie - aktuelle Diagnostik und Therapie: Empfehlungen einer gemeinsamen Arbeitsgruppe der DGHO, ÖGHO, SGH, GPOH und DGTIAxel Matzdorff, Oliver Meyer, Helmut Ostermann, et al.
Annals of Hematology|February 3, 2011
Long-term survival of patients with a history of venous thromboembolismSylvia Elisabeth Reitter, Thomas Waldhoer, Michaela Mayerhofer, et al.
Thrombosis Research|August 19, 2007
Plasma levels of P-selectin are determined by platelet turn-over and the P-selectin Thr715Pro polymorphismSimon Panzer, Sergio Rosales, Heinz Gisslinger, et al.
Thrombosis and Haemostasis|August 12, 2008
Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patientsClaude Négrier, Amy Shapiro, Erik Berntorp, et al.
Thrombosis and Haemostasis|March 30, 2007
The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154Peter Bugert, Ingrid Pabinger, Kathrin Stamer, et al.
Wiener Klinische Wochenschrift|May 5, 2009
Austrian Hemophilia Registry: design, development and set of variablesSylvia Reitter, Werner Streif, Thomas Schabetsberger, et al.
Annals of Hematology|November 24, 2018
Low extracellular vesicle-associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosisLena Hell, Cihan Ay, Florian Posch, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 27, 2021
Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgeryIngrid Pabinger, Vasily Mamonov, Jerzy Windyga, et al.
Journal of Thrombosis and Haemostasis : JTH|May 16, 2025
Bleeding risk and performance of bleeding risk assessment models in patients with venous thromboembolism on anticoagulation: results from the prospective observational bleeding and assess long-term outcomes on health in patients with venous thromboembolism (BACH-VTE) studyTimothy Hoberstorfer, Stephan Nopp, Daniel Steiner, et al.
Thrombosis and Haemostasis|October 9, 2018
Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with CancerElla Grilz, Florian Posch, Oliver Königsbrügge, et al.
Pageof 37